Adenosine inhibits cholangiocarcinoma via a concurrent activation of AMPK and mTORC1 signaling pathways

18 May 2026
0

Adenosine inhibits cholangiocarcinoma via a concurrent activation of AMPK and mTORC1 signaling pathways

Lertsuwan J, Svasti S, Satayavivad J

Anticancer Res. 2026;46(3):1449-1460.

Tags

Share this

Related Posts

Application of the in vivo oxidative stress reporter Hmox1 as mechanistic biomarker of arsenic toxicity, Inesta-Vaquera, F., Navasumrit, P., Henderson, C.J., Frangova, T.G., Honda, T., Dinkova-Kostova, A.T., Ruchirawat, M., Wolf, C.R. Environmental Pollution. 270 (2021).

Recent Posts